Physician

Savan Samir Shah

According to 2025 Medicare claims, Savan Shah (NPI: 1871955096) practices internal medicine in the St. Petersburg-Clearwater-Largo, FL market, with the plurality of this provider's patient population coming from Pinellas, FL. This provider's primary affiliated billing organization is FLORIDA CANCER SPECIALISTS & RESEARCH INSTITUTE, LLC (NPI: 1760590962; TIN: 65-0825133) and primary practice location at 33756-3314.

Shah's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 516 traditional Medicare patients, billed 97,038 HCPCS/CPT codes, and received $1,410,353 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 567 prescription claims across 88 beneficiaries totaling $1,213,940 in drug costs, led by Revlimid (Lenalidomide). Open Payments data shows 91 records totaling $2,162. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $843 and ending at $1,213,940. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$705K$1.4M2019 Medicare payment: $2,255 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $5,823 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $46,014 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $1,410,353 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
20191429$2,255
20203975$5,823
2021N/RN/RN/R
2022N/RN/RN/R
20231404,343$46,014
202451697,038$1,410,353

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$607K$1.2M2016 Drug cost: $843 (USD; Tot_Drug_Cst)2017 Drug cost: $5,758 (USD; Tot_Drug_Cst)2018 Drug cost: $425 (USD; Tot_Drug_Cst)2019 Drug cost: $182 (USD; Tot_Drug_Cst)2020 Drug cost: $1,226 (USD; Tot_Drug_Cst)2021 Drug cost: $4,265 (USD; Tot_Drug_Cst)2023 Drug cost: $11,895 (USD; Tot_Drug_Cst)2024 Drug cost: $1,213,940 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/R12$843
20173279$5,758
20181119$425
2019N/R14$182
20202338$1,226
20211624$4,265
2022N/RN/RN/R
20231224$11,895
202488567$1,213,940

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99223Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes8892$134
99222Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes109114$99
99232Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes90133$61
36415Insertion of needle into vein for collection of blood sample215546$9
85025Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count215640$8

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
RevlimidLenalidomide20525$329,458
NubeqaDarolutamide11330$132,057
EliquisApixaban381,207$23,081
XareltoRivaroxaban12360$6,999
Ondansetron OdtOndansetron65636$902

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.91$2,162Merck Sharp & Dohme LLC
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Savan Samir Shah?

Tedicare shows public-source Medicare data for Savan Samir Shah (NPI 1871955096), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Savan Samir Shah have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Savan Samir Shah?

Savan Samir Shah is linked to FLORIDA CANCER SPECIALISTS & RESEARCH INSTITUTE, LLC (billing NPI 1760590962) in the available physician profile data.

Does Savan Samir Shah have Open Payments data?

Savan Samir Shah has 91 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.